BRIEF-Generation Bio to Apply ctLNP Delivery Technology to Develop siRNA Therapeutics for T Cell-Driven Autoimmune Diseases
ReutersJan 6, 2025 11:16 PM
Jan 6 (Reuters) - Generation Bio Co GBIO.O:
GENERATION BIO TO APPLY CTLNP DELIVERY TECHNOLOGY TO DEVELOP SIRNA THERAPEUTICS FOR T CELL-DRIVEN AUTOIMMUNE DISEASES
Source text: ID:nGNXbZYGJ
Further company coverage: GBIO.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
Investing in Industrials Stocks
TradingKey - Industrials are having a remarkable 2025 recovery, quietly but powerfully. No longer a defensively minded, yield-driven sector, they are riding waves of structural change from geopolitics and AI infrastructure to the great global supply chain reshore. While the S&P 500 continues to...TradingKey
16 hours ago
Amazon Q2 FY2025 Earnings Review: Robust Cloud and AI Growth Coupled with Retail Tariff Challenges
TradingKey - Amazon.com, Inc. (NASDAQ: AMZN) released its Q2 FY2025 earnings on July 31, 2025, after market close, delivering results that surpassed expectations, driven by robust growth in AWS, advertising, and retail segments.TradingKey
21 hours ago
U.S. GDP, PCE, and Fed Rate Decision Commentary: Will U.S. Stocks Continue to Rise?
TradingKey - On 30–31 July 2025, the United States released its latest GDP and PCE data, while the Federal Reserve announced its interest rate decision during the same period.TradingKey
21 hours ago
Berkshire Hathaway FY2025 Second Quarter Earnings Preview
TradingKey - The Q2 2025 earnings report for Berkshire Hathaway is expected to be released on August 2. Below are the market expectations for Berkshire Hathaway’s Q2 2025 revenue and earnings per share (EPS):TradingKey
Thu, Jul 31
[IN-DEPTH ANALYSIS] UnitedHealth (UNH): Can the Healthcare Giant Recover After Its Epic Collapse?
Once a Wall Street sweetheart, UnitedHealth Group (UNH) dominated the US healthcare industry with its unbeatable vertical empire, spanning insurance, clinics, pharmacies, and data analytics.TradingKey
Mon, May 26
.jpg)
